PHARMACEUTICAL VALUE
CREATOR.

CMIC Group pioneered the CRO business in Japan. We started out to support the development of pharmaceuticals, and it now offers greatly expanded services that encompass an entire value-chain of pharmaceutical companies, including manufacturing, sales, and marketing, based on our unique "Pharmaceutical Value Creator (PVC)" business model.

ABOUT OUR COMPANY

WITH UNCHANGING DETERMINATION
AT HEART, WE CHANGE.

CMIC’S CREED is based on the ideas of our founder, Kazuo Nakamura. Right from the start of our business as the first CRO in Japan, the CREED has been the core policy of the company.

READ OUR CREED

ABOUT 80% OF NEW DRUG DEVELOPMENT IN JAPAN
IS SUPPORTED BY CMIC’S EFFORTS.

Breaking ourselves free from preconceived notions, we continue our steps towards challenging unprecendented innovative ideas. Since 25 years ago, we have started as the first CRO in Japan with this mentality.
Today, we are invovled in around 80% of all new pharmaceutical drug development activities in Japan.

Headline News

Our Services

Drug discovery
Industrial research
Bioanalysis / CMC Analytical Testing
Non-clinical
studies
Clinical trial
notification
Clinical
studies
Approval applications
Gaining approval
Drug launch
Manufacturing
Provisioning medical information
Sales
Bioanalysis / CMC Analytical Testing
Post-marketing surveillance / Periodic safety update reports
Re-evaluation

PVC : business model of the CMIC Group

Our Available Areas

WHITE PAPER

The Changing Face of Gloval Clinical Trials: Asia-Pacific as an ldeal Destination for Specialty Biopaharma

Read more

INFOGRAPHIC

CMIC: The Largest Japanese Integrated Service Provider Providing Full Range of Services

Read more

Topics

View all news releases

SHARE